Showing results (1661-1670 of 2,056) with videos related to

Sort By:
Pageof 206
Frontiers in Plant Science|July 3, 2025
Transcriptome and VcCADs gene family analyses reveal mechanisms of blight resistance in rabbiteye blueberryShan-Shan Lu, Wei Liu, Li-Juan Yang, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 11, 2024
Engineering Dual CO2- and Photothermal-Responsive Membranes for Switchable Double Emulsion SeparationHaohao Liu, Yangyang Wang, Bo Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2024
Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitorsMengqing Xie, Tianqing Chu, Xiaorong Dong, et al.
BMC Genomics|June 20, 2024
Comparative transcriptome analysis reveals transcriptional regulation of anthocyanin biosynthesis in purple radish (Raphanus sativus L.)Yi Liu, Chenchen Wang, Haidong Chen, et al.
Phytochemical Analysis : PCA|June 5, 2024
Renal toxicity of Aconitum plants? A study based on a new mass spectrometry scanning strategy and computer virtual screeningYihui Yin, Kai Zhang, Yunpeng Qi, et al.
Genes|December 23, 2023
Genetic Origin and Introgression Pattern of Pingliang Red Cattle Revealed Using Genome-Wide SNP AnalysesYuanqing Wang, Jun Ma, Jing Wang, et al.
Cell Death & Disease|July 28, 2022
m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expressionHeng Zhang, Shao-Qiang Wang, Li Wang, et al.
Plos One|May 4, 2016
The Impact of Variable Degrees of Freedom and Scale Parameters in Bayesian Methods for Genomic Prediction in Chinese Simmental Beef CattleBo Zhu, Miao Zhu, Jicai Jiang, et al.
Journal of Animal Science and Biotechnology|March 15, 2019
Genome wide association study identifies SNPs associated with fatty acid composition in Chinese Wagyu cattleZezhao Wang, Bo Zhu, Hong Niu, et al.
Signal Transduction and Targeted Therapy|May 25, 2025
Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trialQiang Zhang, Mozhi Wang, Yumeng Li, et al.
Pageof 206